Caseware UK (AP4) 2024.0.164 2024.0.164 2026-02-282026-02-28No description of principal activity02025-03-01false0truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08407940 2025-03-01 2026-02-28 08407940 2024-03-01 2025-02-28 08407940 2026-02-28 08407940 2025-02-28 08407940 c:Director1 2025-03-01 2026-02-28 08407940 d:OfficeEquipment 2025-03-01 2026-02-28 08407940 d:OfficeEquipment 2026-02-28 08407940 d:OfficeEquipment 2025-02-28 08407940 d:OfficeEquipment d:OwnedOrFreeholdAssets 2025-03-01 2026-02-28 08407940 d:CurrentFinancialInstruments 2026-02-28 08407940 d:CurrentFinancialInstruments 2025-02-28 08407940 d:CurrentFinancialInstruments d:WithinOneYear 2026-02-28 08407940 d:CurrentFinancialInstruments d:WithinOneYear 2025-02-28 08407940 d:ShareCapital 2026-02-28 08407940 d:ShareCapital 2025-02-28 08407940 d:RetainedEarningsAccumulatedLosses 2026-02-28 08407940 d:RetainedEarningsAccumulatedLosses 2025-02-28 08407940 c:FRS102 2025-03-01 2026-02-28 08407940 c:AuditExempt-NoAccountantsReport 2025-03-01 2026-02-28 08407940 c:FullAccounts 2025-03-01 2026-02-28 08407940 c:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 08407940 2 2025-03-01 2026-02-28 08407940 e:PoundSterling 2025-03-01 2026-02-28 iso4217:GBP xbrli:pure

Registered number: 08407940









MEDICAL FOCUS HEALTHCARE LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 28 FEBRUARY 2026

 
MEDICAL FOCUS HEALTHCARE LTD
REGISTERED NUMBER: 08407940

BALANCE SHEET
AS AT 28 FEBRUARY 2026

2026
2025
Note
£
£

Fixed assets
  

Tangible assets
 4 
2,526
5,260

  
2,526
5,260

Current assets
  

Cash at bank and in hand
 5 
121,412
74,401

  
121,412
74,401

Creditors: amounts falling due within one year
 6 
(46,131)
(41,194)

Net current assets
  
 
 
75,281
 
 
33,207

Total assets less current liabilities
  
77,807
38,467

  

Net assets
  
77,807
38,467


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
77,806
38,466

  
77,807
38,467


Page 1

 
MEDICAL FOCUS HEALTHCARE LTD
REGISTERED NUMBER: 08407940
    
BALANCE SHEET (CONTINUED)
AS AT 28 FEBRUARY 2026

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Dr P S A Taub
Director

Date: 28 October 2026

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
MEDICAL FOCUS HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026

1.


General information

Medical Focus Healthcare Limited is a private company limited by shares.The company was incorporated in England and Wales and the registered office address is Aston House, Cornwall Avenue, London, England, N3 1LF. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are presented in Sterling (£), which is the functional currency of the entity.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
∙the amount of revenue can be measured reliably;
∙it is probable that the Company will receive the consideration due under the contract;
∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and
∙the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 3

 
MEDICAL FOCUS HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026

2.Accounting policies (continued)

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25% straight line method

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 4

 
MEDICAL FOCUS HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026

2.Accounting policies (continued)

 
2.9

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Employees

The Company has no employees other than the directors, who did not receive any remuneration (2025 - £NIL).

The average monthly number of employees, including directors, during the year was 0 (2025 - 0).

Page 5

 
MEDICAL FOCUS HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026

4.


Tangible fixed assets





Office equipment

£



Cost 


At 1 March 2025
14,892



At 28 February 2026

14,892



Depreciation


At 1 March 2025
9,633


Charge for the year
2,733



At 28 February 2026

12,366



Net book value



At 28 February 2026
2,526



At 28 February 2025
5,260


5.


Cash and cash equivalents

2026
2025
£
£

Cash at bank and in hand
121,412
74,401

121,412
74,401



6.


Creditors: Amounts falling due within one year

2026
2025
£
£

Corporation tax
37,469
34,037

Other creditors
4,222
2,157

Accruals and deferred income
4,440
5,000

46,131
41,194


Page 6

 
MEDICAL FOCUS HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026

7.


Related party transactions

At the balance sheet date the company owed a sum of £4,222 (2025: £2,157) to the director, Dr P S A Taub. The loan is interest free and repayable on demand. 

 
Page 7